| Symbol |
Name |
Standardized Value |
|
PRL
|
prolactin
|
4.0
|
|
TRH
|
thyrotropin-releasing hormone
|
3.24
|
|
POMC
|
proopiomelanocortin
|
3.163
|
|
PRLR
|
prolactin receptor
|
3.161
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
3.09
|
|
SHBG
|
sex hormone-binding globulin
|
3.059
|
|
DRD2
|
dopamine receptor D2
|
3.049
|
|
AMH
|
anti-Mullerian hormone
|
2.932
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
2.911
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
2.79
|
|
INS
|
insulin
|
2.766
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
2.698
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
2.614
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
2.564
|
|
GHRH
|
growth hormone releasing hormone
|
2.498
|
|
SST
|
somatostatin
|
2.451
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
2.361
|
|
CSH1
|
chorionic somatomammotropin hormone 1 (placental lactogen)
|
2.31
|
|
MEN1
|
multiple endocrine neoplasia I
|
2.304
|
|
TRIM32
|
tripartite motif containing 32
|
2.291
|
|
CSH2
|
chorionic somatomammotropin hormone 2
|
2.286
|
|
TBX19
|
T-box 19
|
2.236
|
|
LEP
|
leptin
|
2.236
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
2.211
|
|
GH1
|
growth hormone 1
|
2.182
|
|
HTR2B
|
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled
|
2.172
|
|
AVP
|
arginine vasopressin
|
2.155
|
|
GHR
|
growth hormone receptor
|
2.141
|
|
DRD3
|
dopamine receptor D3
|
2.133
|
|
ESR1
|
estrogen receptor 1
|
2.133
|
|
CRH
|
corticotropin releasing hormone
|
2.123
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
2.121
|
|
GPR101
|
G protein-coupled receptor 101
|
2.107
|
|
PTH
|
parathyroid hormone
|
2.071
|
|
GH2
|
growth hormone 2
|
2.059
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
2.047
|
|
TH
|
tyrosine hydroxylase
|
2.021
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
2.004
|
|
FSHR
|
follicle stimulating hormone receptor
|
1.972
|
|
VIP
|
vasoactive intestinal peptide
|
1.953
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
1.938
|
|
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase)
|
1.931
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
1.925
|
|
TPO
|
thyroid peroxidase
|
1.917
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
1.916
|
|
POU1F1
|
POU class 1 homeobox 1
|
1.908
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
1.885
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
1.878
|
|
NPY
|
neuropeptide Y
|
1.877
|
|
IL6
|
interleukin 6
|
1.86
|
|
CRP
|
C-reactive protein, pentraxin-related
|
1.856
|
|
GCG
|
glucagon
|
1.855
|
|
TAC3
|
tachykinin 3
|
1.843
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
1.834
|
|
SSTR5
|
somatostatin receptor 5
|
1.831
|
|
TG
|
thyroglobulin
|
1.809
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
1.808
|
|
ALB
|
albumin
|
1.803
|
|
GNAS
|
GNAS complex locus
|
1.801
|
|
KISS1R
|
KISS1 receptor
|
1.786
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
1.777
|
|
MAOB
|
monoamine oxidase B
|
1.755
|
|
TSHB
|
thyroid stimulating hormone, beta
|
1.745
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
1.742
|
|
PRLH
|
prolactin releasing hormone
|
1.741
|
|
PPIG
|
peptidylprolyl isomerase G (cyclophilin G)
|
1.734
|
|
JAK2
|
Janus kinase 2
|
1.73
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
1.729
|
|
MAOA
|
monoamine oxidase A
|
1.727
|
|
PROP1
|
PROP paired-like homeobox 1
|
1.725
|
|
TNF
|
tumor necrosis factor
|
1.722
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
1.718
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
1.713
|
|
INSR
|
insulin receptor
|
1.713
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
1.709
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
1.708
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
1.706
|
|
IL1B
|
interleukin 1, beta
|
1.699
|
|
GAST
|
gastrin
|
1.697
|
|
FGA
|
fibrinogen alpha chain
|
1.696
|
|
DENND1A
|
DENN/MADD domain containing 1A
|
1.695
|
|
DRD4
|
dopamine receptor D4
|
1.675
|
|
AR
|
androgen receptor
|
1.674
|
|
SSTR2
|
somatostatin receptor 2
|
1.668
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
1.668
|
|
COMT
|
catechol-O-methyltransferase
|
1.659
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
1.654
|
|
DRD1
|
dopamine receptor D1
|
1.646
|
|
SERPINA7
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7
|
1.635
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
1.633
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1.621
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
1.619
|
|
GAL
|
galanin/GMAP prepropeptide
|
1.612
|
|
HSD3B1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
1.609
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
1.6
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
1.585
|
|
PDYN
|
prodynorphin
|
1.572
|
|
TGFB1
|
transforming growth factor, beta 1
|
1.567
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
1.567
|
|
PGR
|
progesterone receptor
|
1.566
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
1.565
|
|
HTR1D
|
5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled
|
1.561
|
|
HTR7
|
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled
|
1.559
|
|
PRKACG
|
protein kinase, cAMP-dependent, catalytic, gamma
|
1.558
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
1.556
|
|
GHRHR
|
growth hormone releasing hormone receptor
|
1.553
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
1.552
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
1.546
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
1.534
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
1.531
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
1.527
|
|
IFNG
|
interferon, gamma
|
1.514
|
|
IL2
|
interleukin 2
|
1.509
|
|
OMA1
|
OMA1 zinc metallopeptidase
|
1.487
|
|
HRH1
|
histamine receptor H1
|
1.484
|
|
ARRB2
|
arrestin, beta 2
|
1.484
|
|
BDNF
|
brain-derived neurotrophic factor
|
1.483
|
|
ACE
|
angiotensin I converting enzyme
|
1.48
|
|
LEPR
|
leptin receptor
|
1.475
|
|
PXDNL
|
peroxidasin-like
|
1.475
|
|
REN
|
renin
|
1.471
|
|
PXDN
|
peroxidasin
|
1.47
|
|
HESX1
|
HESX homeobox 1
|
1.469
|
|
GHSR
|
growth hormone secretagogue receptor
|
1.468
|
|
TP53
|
tumor protein p53
|
1.462
|
|
IGSF1
|
immunoglobulin superfamily, member 1
|
1.46
|
|
SYP
|
synaptophysin
|
1.454
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
1.451
|
|
CHGA
|
chromogranin A
|
1.448
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
1.446
|
|
GDF9
|
growth differentiation factor 9
|
1.444
|
|
STAR
|
steroidogenic acute regulatory protein
|
1.425
|
|
RHCG
|
Rh family, C glycoprotein
|
1.425
|
|
PROKR2
|
prokineticin receptor 2
|
1.423
|
|
TAC1
|
tachykinin, precursor 1
|
1.422
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
1.421
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
1.412
|
|
IL10
|
interleukin 10
|
1.407
|
|
BMP15
|
bone morphogenetic protein 15
|
1.405
|
|
PHOX2B
|
paired-like homeobox 2b
|
1.4
|
|
SSTR1
|
somatostatin receptor 1
|
1.4
|
|
CD4
|
CD4 molecule
|
1.398
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
1.396
|
|
HTR6
|
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled
|
1.396
|
|
HRH2
|
histamine receptor H2
|
1.391
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
1.386
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
1.382
|
|
PPY
|
pancreatic polypeptide
|
1.378
|
|
USP8
|
ubiquitin specific peptidase 8
|
1.371
|
|
IRS1
|
insulin receptor substrate 1
|
1.371
|
|
F2
|
coagulation factor II (thrombin)
|
1.369
|
|
ESX1
|
ESX homeobox 1
|
1.369
|
|
IL1A
|
interleukin 1, alpha
|
1.364
|
|
LRTOMT
|
leucine rich transmembrane and O-methyltransferase domain containing
|
1.36
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
1.359
|
|
AOPEP
|
aminopeptidase O (putative)
|
1.358
|
|
ACTB
|
actin, beta
|
1.356
|
|
IGF2
|
insulin-like growth factor 2
|
1.349
|
|
CD1A
|
CD1a molecule
|
1.34
|
|
EGF
|
epidermal growth factor
|
1.336
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
1.335
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
1.334
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
1.332
|
|
GRM2
|
glutamate receptor, metabotropic 2
|
1.331
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
1.328
|
|
MEA1
|
male-enhanced antigen 1
|
1.325
|
|
AGRP
|
agouti related neuropeptide
|
1.324
|
|
MC4R
|
melanocortin 4 receptor
|
1.32
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
1.315
|
|
DHRS11
|
dehydrogenase/reductase (SDR family) member 11
|
1.315
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
1.314
|
|
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
|
1.312
|
|
ANOS1
|
anosmin 1
|
1.307
|
|
TACR3
|
tachykinin receptor 3
|
1.307
|
|
LALBA
|
lactalbumin, alpha-
|
1.3
|
|
UGT1A4
|
UDP glucuronosyltransferase 1 family, polypeptide A4
|
1.296
|
|
ATP12A
|
ATPase, H+/K+ transporting, nongastric, alpha polypeptide
|
1.295
|
|
RAMP2
|
receptor (G protein-coupled) activity modifying protein 2
|
1.292
|
|
PTHLH
|
parathyroid hormone-like hormone
|
1.286
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
1.285
|
|
HSD3B2
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2
|
1.284
|
|
DRD5
|
dopamine receptor D5
|
1.284
|
|
TAAR1
|
trace amine associated receptor 1
|
1.281
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
1.275
|
|
ATP4A
|
ATPase, H+/K+ exchanging, alpha polypeptide
|
1.275
|
|
FST
|
follistatin
|
1.273
|
|
TRHR
|
thyrotropin-releasing hormone receptor
|
1.27
|
|
CD1E
|
CD1e molecule
|
1.264
|
|
PDE10A
|
phosphodiesterase 10A
|
1.264
|
|
LHX3
|
LIM homeobox 3
|
1.26
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
1.259
|
|
CD8A
|
CD8a molecule
|
1.258
|
|
NTS
|
neurotensin
|
1.256
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
1.252
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
1.251
|
|
CD1B
|
CD1b molecule
|
1.246
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
1.239
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
1.235
|
|
HNF1A
|
HNF1 homeobox A
|
1.234
|
|
ATP5PO
|
ATP synthase peripheral stalk subunit OSCP
|
1.226
|
|
RETN
|
resistin
|
1.226
|
|
SMR3A
|
submaxillary gland androgen regulated protein 3A
|
1.226
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
1.222
|
|
LHX4
|
LIM homeobox 4
|
1.221
|
|
MLN
|
motilin
|
1.215
|
|
CISH
|
cytokine inducible SH2-containing protein
|
1.214
|
|
RETNLB
|
resistin like beta
|
1.213
|
|
CSN2
|
casein beta
|
1.207
|
|
UNK
|
unkempt family zinc finger
|
1.199
|
|
CD68
|
CD68 molecule
|
1.197
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
1.194
|
|
ARRB1
|
arrestin, beta 1
|
1.194
|
|
AMHR2
|
anti-Mullerian hormone receptor, type II
|
1.193
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
1.193
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
1.193
|
|
SSTR3
|
somatostatin receptor 3
|
1.192
|
|
LPL
|
lipoprotein lipase
|
1.191
|
|
KLK3
|
kallikrein-related peptidase 3
|
1.185
|
|
RAB5B
|
RAB5B, member RAS oncogene family
|
1.184
|
|
TSHR
|
thyroid stimulating hormone receptor
|
1.179
|
|
HOXA10
|
homeobox A10
|
1.178
|
|
CD1C
|
CD1c molecule
|
1.178
|
|
APOB
|
apolipoprotein B
|
1.175
|
|
OXTR
|
oxytocin receptor
|
1.175
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
1.171
|
|
LHB
|
luteinizing hormone beta polypeptide
|
1.166
|
|
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa)
|
1.165
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
1.163
|
|
CD1D
|
CD1d molecule
|
1.157
|
|
SLCO2A1
|
solute carrier organic anion transporter family, member 2A1
|
1.156
|
|
CREB1
|
cAMP responsive element binding protein 1
|
1.154
|
|
IL4
|
interleukin 4
|
1.154
|
|
NKX2-1
|
NK2 homeobox 1
|
1.154
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
1.148
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
1.146
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.144
|
|
HTR5A
|
5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled
|
1.139
|
|
CCK
|
cholecystokinin
|
1.139
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
1.133
|
|
TRHDE
|
thyrotropin-releasing hormone degrading enzyme
|
1.128
|
|
TGFA
|
transforming growth factor, alpha
|
1.126
|
|
AFP
|
alpha-fetoprotein
|
1.116
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
1.115
|
|
USP48
|
ubiquitin specific peptidase 48
|
1.105
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
1.103
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
1.102
|
|
SNED1
|
sushi, nidogen and EGF-like domains 1
|
1.1
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
1.097
|
|
GRM3
|
glutamate receptor, metabotropic 3
|
1.096
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
1.095
|
|
IL17A
|
interleukin 17A
|
1.09
|
|
HMGA2
|
high mobility group AT-hook 2
|
1.086
|
|
HTR3A
|
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
|
1.086
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
1.085
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
1.083
|
|
IRF1
|
interferon regulatory factor 1
|
1.082
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
1.082
|
|
EPO
|
erythropoietin
|
1.081
|
|
PNMT
|
phenylethanolamine N-methyltransferase
|
1.08
|
|
FGF4
|
fibroblast growth factor 4
|
1.08
|
|
DISC1
|
disrupted in schizophrenia 1
|
1.078
|
|
CTSD
|
cathepsin D
|
1.078
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
1.078
|
|
FBN3
|
fibrillin 3
|
1.075
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
1.072
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
1.072
|
|
RRAD
|
Ras-related associated with diabetes
|
1.072
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
1.07
|
|
TOX3
|
TOX high mobility group box family member 3
|
1.068
|
|
PTTG1
|
pituitary tumor-transforming 1
|
1.067
|
|
SOX3
|
SRY (sex determining region Y)-box 3
|
1.065
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
1.063
|
|
FGF23
|
fibroblast growth factor 23
|
1.061
|
|
CDC73
|
cell division cycle 73
|
1.061
|
|
PAEP
|
progestagen-associated endometrial protein
|
1.061
|
|
GDNF
|
glial cell derived neurotrophic factor
|
1.058
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
1.057
|
|
PVALB
|
parvalbumin
|
1.057
|
|
PCNA
|
proliferating cell nuclear antigen
|
1.055
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
1.055
|
|
LIF
|
leukemia inhibitory factor
|
1.053
|
|
IFNA1
|
interferon, alpha 1
|
1.053
|
|
NPFFR1
|
neuropeptide FF receptor 1
|
1.05
|
|
PLG
|
plasminogen
|
1.05
|
|
CD40LG
|
CD40 ligand
|
1.045
|
|
SERPINA12
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12
|
1.044
|
|
FOXO1
|
forkhead box O1
|
1.042
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
1.039
|
|
OPRM1
|
opioid receptor, mu 1
|
1.037
|
|
FGF17
|
fibroblast growth factor 17
|
1.029
|
|
GATA3
|
GATA binding protein 3
|
1.028
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
1.027
|
|
TPH1
|
tryptophan hydroxylase 1
|
1.017
|
|
SLC35A2
|
solute carrier family 35 (UDP-galactose transporter), member A2
|
1.017
|
|
TNP1
|
transition protein 1 (during histone to protamine replacement)
|
1.016
|
|
FGF9
|
fibroblast growth factor 9
|
1.016
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
1.016
|
|
FGF18
|
fibroblast growth factor 18
|
1.013
|
|
GPX3
|
glutathione peroxidase 3
|
1.01
|
|
FGF10
|
fibroblast growth factor 10
|
1.006
|
|
QDPR
|
quinoid dihydropteridine reductase
|
1.006
|
|
FAM90A1
|
family with sequence similarity 90, member A1
|
1.005
|
|
FMR1
|
fragile X mental retardation 1
|
1.005
|
